Abstract:Cardiovascular diseases (CVD) remain the leading cause of death within industrialized nations as well as an increasing cause of mortality and morbidity in many developing countries. Smoking, alcohol consumption and increased level of blood cholesterol are the main CVD risk factors. Other factors, such as the prevalence of overweight/obesity and diabetes, have increased considerably in recent decades and are indirect causes of CVD. Among CVDs, the acute coronary syndrome (ACS) represents the most common cause of emergency hospital admission. Since the prognosis of ACS is directly associated with timely initiation of revascularization, missed, misdiagnosis or late diagnosis have unfavorable medical implications. Early ACS diagnosis can reduce complications and risk of recurrence, finally decreasing the economic burden posed on the health care system as a whole. To decrease the risk of ACS and related CVDs and to reduce associated costs to healthcare systems, a fast management of patients with chest pain has become crucial and urgent. Despite great efforts, biochemical diagnostic approaches of CVDs remain difficult and controversial medical challenges as cardiac biomarkers should be rapidly released into the blood at the time of ischemia and persistent for a sufficient length of time to allow diagnostics, with tests that should be rapid, easy to perform and relatively inexpensive. Early biomarker assessments have involved testing for the total enzyme activity of aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and creatine kinase (CK), which cardiac troponins being the main accepted biomarkers for diagnosing myocardial injury and acute myocardial infarction (AMI). To allow rapid diagnosis, it is necessary to replace the traditional biochemical assays by cardiac biosensor platforms. Among the numerous of possibilities existing today, electrochemical biosensors are important players as they have many of the required characteristics for point-of-care tests. Electrochemical based cardiac biosensors are highly adapted for monitoring the onset and progress of cardiovascular diseases in a fast and accurate manner, while being cheap and scalable devices. This review outlines the state of the art in the development of cardiac electrochemical sensors for the detection of different cardiac biomarkers ranging from troponin to BNP, N-terminal proBNP, and others.

Research progress of electrochemistry in detecting markers of cardiovascular disease

Nanomaterial-based biosensors for measurement of lipids and lipoproteins towards point-of-care of cardiovascular disease.

Electrochemical Sensors for Clinic Analysis

Recent Advances in Cardiovascular Disease Biosensors and Monitoring Technologies

Advancements in Electrochemical Biosensing of Cardiovascular Disease Biomarkers

Electrochemical-Based Biosensors: New Diagnosis Platforms for Cardiovascular Disease

Electrochemical cardiovascular platforms: Current state of the art and beyond

Advancements in electrochemical immunosensors towards point-of-care detection of cardiac biomarkers

Recent advances in designing nanomaterial based biointerfaces for electrochemical biosensing cardiovascular biomarkers

Advances in heart failure monitoring: Biosensors targeting molecular markers in peripheral bio-fluids

[Application of microfluidic assays for cardiovascular disease markers in early warning and rapid diagnosis]

The Biomarkers for Acute Myocardial Infarction and Heart Failure.

Advances in Electrochemical Biosensors for the Detection of Common Oral Diseases

Electrochemical biosensors for pathogenic microorganisms detection based on recognition elements

Recent advances in disease diagnosis based on electrochemical-optical dual-mode detection method

Development Toward a Triple-Marker Biosensor for Diagnosing Cardiovascular Disease

Application and progress of electrochemical biosensors for the detection of pathogenic viruses

Electrochemical protein biosensors for disease marker detection: progress and opportunities

A review of biosensor technologies for blood biomarkers toward monitoring cardiovascular diseases at the point-of-care

Mechanical Sensors for Cardiovascular Monitoring: From Battery-Powered to Self-Powered

Recent advances of electrochemical sensors for detecting and monitoring ROS/RNS